AAAAAA
Results:
1-9
|
Results: 9
Authors:
Buske, C
Feuring-Buske, M
Antonchuk, J
Rosten, P
Hogge, DE
Eaves, CJ
Humphries, RK
Citation: C. Buske et al., Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and invivo, BLOOD, 97(8), 2001, pp. 2286-2292
Authors:
Feuring-Buske, M
Hogge, DE
Citation: M. Feuring-buske et De. Hogge, Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia, BLOOD, 97(12), 2001, pp. 3882-3889
Authors:
Feuring-Buske, M
Kneba, M
Unterhalt, M
Engert, A
Gramatzki, M
Hiller, E
Trumper, L
Brugger, W
Ostermann, H
Atzpodien, J
Hallek, M
Aulitzky, E
Hiddemann, W
Citation: M. Feuring-buske et al., IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group, ANN HEMATOL, 79(9), 2000, pp. 493-500
Authors:
Feuring-Buske, M
Buske, C
Unterhalt, M
Hiddemann, W
Citation: M. Feuring-buske et al., Recent advances in antigen-targeted therapy in non-Hodgkin's lymphoma, ANN HEMATOL, 79(4), 2000, pp. 167-174
Authors:
Feuring-Buske, M
Frankel, A
Gerhard, B
Hogge, D
Citation: M. Feuring-buske et al., Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells, EXP HEMATOL, 28(12), 2000, pp. 1390-1400
Authors:
Buske, C
Feuring-Buske, M
Unterhalt, M
Hiddemann, W
Citation: C. Buske et al., New advances in the treatment of non-Hodgkin lymphoma with monoclonal antibodies, DEUT MED WO, 124(27), 1999, pp. 842-847
Authors:
Buske, C
Feuring-Buske, M
Unterhalt, M
Hiddemann, W
Citation: C. Buske et al., Monoclonal antibody therapy for B cell non-Hodgkin's lymphomas: Emerging concepts of a tumour-targeted strategy, EUR J CANC, 35(4), 1999, pp. 549-557
Authors:
Feuring-Buske, M
Haase, D
Buske, C
Hiddemann, W
Wormann, B
Citation: M. Feuring-buske et al., Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission, LEUKEMIA, 13(3), 1999, pp. 386-392
Authors:
Braess, J
Wegendt, C
Feuring-Buske, M
Riggert, J
Kern, W
Hiddemann, W
Schleyer, E
Citation: J. Braess et al., Leukaemic blasts differ from normal bone marrow mononuclear cells and CD34(+) haemopoietic stem cells in their metabolism of cytosine arabinoside, BR J HAEM, 105(2), 1999, pp. 388-393
Risultati:
1-9
|